ASRS
XENE icon

Arizona State Retirement System’s Xenon Pharmaceuticals XENE Stock Holding History

Arizona State Retirement System’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
22,382
+513
+2% +$28.5K 0.01% 989
2026
Q1 		$1.27M Buy
21,869
+5,690
+35% +$262K 0.01% 959
2025
Q4 		$725K Sell
16,179
-3,111
-16% -$131K ﹤0.01% 1278
2025
Q3 		$774K Buy
19,290
+334
+2% +$11.8K ﹤0.01% 1273
2025
Q2 		$593K Buy
18,956
+377
+2% +$12.3K ﹤0.01% 1376
2025
Q1 		$623K Sell
18,579
-87
-0.5% -$3.3K ﹤0.01% 1310
2024
Q4 		$732K Buy
18,666
+194
+1% +$8.02K ﹤0.01% 1294
2024
Q3 		$727K Buy
18,472
+523
+3% +$21.1K ﹤0.01% 1284
2024
Q2 		$700K Buy
17,949
+688
+4% +$27.5K ﹤0.01% 1247
2024
Q1 		$743K Sell
17,261
-291
-2% -$13.4K 0.01% 1214
2023
Q4 		$808K Buy
17,552
+3,074
+21% +$109K 0.01% 1177
2023
Q3 		$495K Buy
14,478
+313
+2% +$11.7K ﹤0.01% 1384
2023
Q2 		$545K Buy
14,165
+574
+4% +$22.8K ﹤0.01% 1362
2023
Q1 		$486K Buy
13,591
+414
+3% +$15.3K ﹤0.01% 1408
2022
Q4 		$520K Buy
13,177
+750
+6% +$27.3K 0.01% 1354
2022
Q3 		$449K Buy
12,427
+1,930
+18% +$69.4K ﹤0.01% 1383
2022
Q2 		$319K Sell
10,497
-659
-6% -$19.9K ﹤0.01% 1635
2022
Q1 		$341K Buy
11,156
+477
+4% +$14.3K ﹤0.01% 1714
2021
Q4 		$334K Buy
+10,679
New +$319K ﹤0.01% 1773

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Arizona State Retirement System's XENE Position: Q2 2026 in Review

Arizona State Retirement System increased its Xenon Pharmaceuticals (XENE) stake by 2.3% in Q2 2026, buying an estimated $28.5K and bringing the position to 22,382 shares worth $1.35M. The position accounts for 0.01% of the portfolio, ranked #989.

Arizona State Retirement System first reported a position in XENE in Q4 2021 and has held it in 19 quarters since. 316 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Arizona State Retirement System held 22,382 shares of Xenon Pharmaceuticals worth $1.35M as of Q2 2026.
  • Arizona State Retirement System bought 513 Xenon Pharmaceuticals shares in Q2 2026, an estimated $28.5K.
  • Xenon Pharmaceuticals made up 0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #989 holding.
  • Arizona State Retirement System first reported a position in Xenon Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 316 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.